Jun-Ichi Kashiwakura

10PUBLICATIONS
14CO-AUTHORS
Tumour immunologyAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 27, 2025
STAP-1-derived peptide suppresses TCR-mediated T cell activation and ameliorates immune diseases by inhibiting STAP-1-LCK binding.

Yuto Sasaki, Kota Kagohashi, Shoya Kawahara

|Feb 05, 2024
Role of Signal-Transducing Adaptor Protein-1 for T Cell Activation and Pathogenesis of Autoimmune Demyelination and Airway Inflammation.

Kota Kagohashi, Yuto Sasaki, Kiyotaka Ozawa

|Sep 05, 2023
STAP-2 negatively regulates BCR-mediated B cell activation by recruiting tyrosine-protein kinase CSK to LYN.

Jun-Ichi Kashiwakura, Shoya Kawahara, Iori Inagaki

|Dec 23, 2022
The Functional Properties and Physiological Roles of Signal-Transducing Adaptor Protein-2 in the Pathogenesis of Inflammatory and Immune Disorders.

Jun-Ichi Kashiwakura, Kenji Oritani, Tadashi Matsuda

|Jun 20, 2022
STAP-2 Is a Novel Positive Regulator of TCR-Proximal Signals.

Kodai Saitoh, Jun-Ichi Kashiwakura, Kota Kagohashi

|Jun 20, 2022
Identification of RPL15 60S Ribosomal Protein as a Novel Topotecan Target Protein That Correlates with DAMP Secretion and Antitumor Immune Activation.

Shunsuke Yamada, Yuichi Kitai, Takashi Tadokoro

Pageof 2

Frequent Collaborators

7 joint publications

Tadashi Matsuda

6 joint publications

Ryuta Muromoto

2 joint publications

Jun Toda

2 joint publications

Kenji Oritani